High materiality7/10
Immix Biopharma price target raised to $25 from $20 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $25 from $20 by H.C. Wainwright; posted price $9.72; priceChangeSinceSignal +12.86.
- Target raised to $25 from $20; posted price $9.72; priceChangeSinceSignal +12.86.
Key facts
- 01
Target: $25
- 02
Posted price: $9.72
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Robert Burns
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.